Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search

Cardiovascular Pharmacology

Citations 31-40 of 92 total displayed.

Past content (since Jan 1999):

Articles
Fluvastatin Prevents Renal Dysfunction and Vascular NO Deficit in Apolipoprotein E-Deficient Mice
Marianne Gervais, Sandrine Pons, Antonino Nicoletti, Claudine Cosson, Jean-François Giudicelli, and Christine Richer
Arterioscler Thromb Vasc Biol published December 12, 2002, doi:10.1161/01.ATV.0000051404.84665.49 [Abstract]  

Vascular Biology
Pharmacological Potentiation of Natriuretic Peptide Limits Polymorphonuclear Neutrophil-Vascular Cell Interactions
El Mostafa Mtairag, Xavier Houard, Samira Rais, Catherine Pasquier, Mounia Oudghiri, Marie-Paule Jacob, Olivier Meilhac, and Jean-Baptiste Michel
Arterioscler Thromb Vasc Biol 2002;22:1824-1831; published online before print as doi:10.1161/01.ATV.0000037102.31086.F4 [Abstract] [Full text]  

Editorials
Re-endothelialization Via Bone Marrow-Derived Progenitor Cells: Still Another Target of Statins in Vascular Disease
Johan Thyberg
Arterioscler Thromb Vasc Biol 2002;22:1509-1511, doi:10.1161/01.ATV.0000036415.04486.01 [Full text]  

Articles
Pharmacological Potentiation of Natriuretic Peptide Limits Polymorphonuclear Neutrophil-Vascular Cell Interactions
El Mostafa Mtairag, Xavier Houard, Samira Rais, Catherine Pasquier, Mounia Oudghiri, Marie-Paule Jacob, Olivier Meilhac, and Jean-Baptiste Michel
Arterioscler Thromb Vasc Biol published September 12, 2002, doi:10.1161/01.ATV.0000037102.31086.F4 [Abstract]  

Vascular Biology
Inhibition of Renin-Angiotensin System Ameliorates Endothelial Dysfunction Associated With Aging in Rats
Yasushi Mukai, Hiroaki Shimokawa, Midoriko Higashi, Keiko Morikawa, Tetsuya Matoba, Junko Hiroki, Ikuko Kunihiro, Hassan M.A. Talukder, and Akira Takeshita
Arterioscler Thromb Vasc Biol 2002;22:1445-1450; published online before print as doi:10.1161/01.ATV.0000029121.63691.CE [Abstract] [Full text]  

Atherosclerosis and Lipoproteins
Statins Reduce Inflammation in Atheroma of Nonhuman Primates Independent of Effects on Serum Cholesterol
Galina K. Sukhova, J. Koudy Williams, and Peter Libby
Arterioscler Thromb Vasc Biol 2002;22:1452-1458; published online before print as doi:10.1161/01.ATV.0000030360.72503.56 [Abstract] [Full text]  

Atherosclerosis and Lipoproteins
Angiotensin II Type 1 Receptor Antagonism Improves Hypercholesterolemia-Associated Endothelial Dysfunction
Sven Wassmann, Stefan Hilgers, Ulrich Laufs, Michael Böhm, and Georg Nickenig
Arterioscler Thromb Vasc Biol 2002;22:1208-1212; published online before print as doi:10.1161/01.ATV.0000022847.38083.B6 [Abstract] [Full text]  

Atherosclerosis and Lipoproteins
Propagermanium Reduces Atherosclerosis in Apolipoprotein E Knockout Mice via Inhibition of Macrophage Infiltration
Tomoya Yamashita, Seinosuke Kawashima, Masanori Ozaki, Masayuki Namiki, Nobutaka Inoue, Ken-ichi Hirata, and Mitsuhiro Yokoyama
Arterioscler Thromb Vasc Biol 2002;22:969-974; published online before print as doi:10.1161/01.ATV.0000019051.88366.9C [Abstract] [Full text]  

Articles
Angiotensin II Type 1 Receptor Antagonism Improves Hypercholesterolemia-Associated Endothelial Dysfunction
Sven Wassmann, Stefan Hilgers, Ulrich Laufs, Michael Böhm, and Georg Nickenig
Arterioscler Thromb Vasc Biol published May 23, 2002, doi:10.1161/01.ATV.0000022847.38083.B6 [Abstract]  

Brief Reviews
Pleiotropic Actions of Peroxisome Proliferator–Activated Receptors in Lipid Metabolism and Atherosclerosis
O. Barbier, I. Pineda Torra, Y. Duguay, C. Blanquart, J.-C. Fruchart, C. Glineur, and B. Staels
Arterioscler Thromb Vasc Biol 2002;22:717-726; published online before print as doi:10.1161/01.ATV.0000015598.86369.04 [Abstract] [Full text]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10

* Subspecialty Collections Home

* Show  Cardiovascular Pharmacology
 collections from other journals.

* Related collections:
 Treatment
 Ablation/ICD/surgery
 Behavioral/psychosocial - treatment
 Cardiovascular Pharmacology
 Catheter-based coronary and valvular interventions: other
 Catheter-based coronary interventions: stents
 Compliance/Adherence
 CPR and emergency cardiac care
 Exercise/exercise testing/rehabilitation
 Pacemaker
 Primary prevention
 Restenosis
 Secondary prevention
 Other Treatment